Literature DB >> 8997227

Effect of perfusion rate on the time course of insulin-mediated skeletal muscle glucose uptake.

A D Baron1, G Brechtel-Hook, A Johnson, J Cronin, R Leaming, H O Steinberg.   

Abstract

To better define the time course of skeletal muscle glucose uptake and its modulation by changes in perfusion, we performed systemic euglycemic-hyperinsulinemic clamps (40 mU.m-2.min-1) for a 90-min period in a group of lean, insulin-sensitive subjects (n = 9) on two occasions (approximately 4 wk apart) with insulin-mediated vasodilation intact or inhibited. Insulin-mediated vasodilation was inhibited by an intrafemoral artery infusion of NG-monomethyl-L-arginine (L-NMMA), a specific inhibitor of nitric oxide synthase. During the study, leg blood flow (LBF) and arteriovenous glucose difference (AVG delta) were measured every 10 min; leg glucose uptake (LGU) was calculated as LGU = LBF x AVG delta. The systemic insulin infusion caused a time-dependent increase in LBF from 0.194 +/- 0.024 to 0.349 +/- 0.046 l/min (P < 0.01). The intrafemoral artery infusion of L-NMMA completely inhibited this increase in LBF. AVG delta, LGU, and whole body glucose disposal rates increased in a time-dependent manner in both studies. The maximum AVG delta was lower with insulin-mediated vasodilation intact than when inhibited (25.9 +/- 2.5 vs. 35.0 +/- 1.6 mg/dl, P < 0.001). The time to achieve half-maximal (T1/2) AVG delta was somewhat longer with insulin-mediated vasodilation intact compared with inhibited (35.6 +/- 4.1 vs. 29.7 +/- 1.6 min, P < 0.01). Maximal LGU was 93.9 +/- 26.8 and 57.2 +/- 11.6 mg/min (P < 0.005), and the T1/2 LGU was 50.2 +/- 16.0 and 36.3 +/- 8.8 min (P = 0.1) during intact and inhibited insulin-mediated vasodilation, respectively. Thus insulin-mediated vasodilation has a modest effect in slowing the time course at which insulin stimulates glucose uptake but has a marked effect in augmenting the maximal rate of insulin-stimulated glucose uptake in skeletal muscle. Impaired insulin-mediated vasodilation, as observed in patients with essential hypertension, may explain, at least in part, the insulin resistance observed in these patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997227     DOI: 10.1152/ajpendo.1996.271.6.E1067

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  29 in total

Review 1.  The metabolic syndrome and the heart--a considered opinion.

Authors:  J G Leichman; V R Lavis; D Aguilar; C R Wilson; H Taegtmeyer
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

Review 2.  Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

Authors:  Corey E Tabit; William B Chung; Naomi M Hamburg; Joseph A Vita
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

3.  Skeletal muscle microvascular insulin resistance in type 2 diabetes is not improved by eight weeks of regular walking.

Authors:  Lauren K Park; Elizabeth J Parks; Ryan J Pettit-Mee; Makenzie L Woodford; Thaysa Ghiarone; James A Smith; Allan R K Sales; Luis A Martinez-Lemus; Camila Manrique-Acevedo; Jaume Padilla
Journal:  J Appl Physiol (1985)       Date:  2020-07-02

4.  Increased endothelial shear stress improves insulin-stimulated vasodilatation in skeletal muscle.

Authors:  Lauren K Walsh; Thaysa Ghiarone; T Dylan Olver; Areli Medina-Hernandez; Jenna C Edwards; Pamela K Thorne; Craig A Emter; Jonathan R Lindner; Camila Manrique-Acevedo; Luis A Martinez-Lemus; Jaume Padilla
Journal:  J Physiol       Date:  2018-11-24       Impact factor: 5.182

5.  Seven days of aerobic exercise training improves conduit artery blood flow following glucose ingestion in patients with type 2 diabetes.

Authors:  Catherine R Mikus; Seth T Fairfax; Jessica L Libla; Leryn J Boyle; Lauro C Vianna; Douglas J Oberlin; Grace M Uptergrove; Shekhar H Deo; Areum Kim; Jill A Kanaley; Paul J Fadel; John P Thyfault
Journal:  J Appl Physiol (1985)       Date:  2011-07-07

6.  Sympathetically mediated increases in cardiac output, not restraint of peripheral vasodilation, contribute to blood pressure maintenance during hyperinsulinemia.

Authors:  Jacqueline K Limberg; James A Smith; Rogerio N Soares; Jennifer L Harper; Keeley N Houghton; Dain W Jacob; Michael T Mozer; Zachary I Grunewald; Blair D Johnson; Timothy B Curry; Tracy Baynard; Camila Manrique-Acevedo; Jaume Padilla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-06-05       Impact factor: 4.733

Review 7.  Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases.

Authors:  Ivonne Hernandez Schulman; Ming-Sheng Zhou
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

Review 8.  Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium.

Authors:  Michelle A Vincent; Monica Montagnani; Michael J Quon
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

Review 9.  Skeletal muscle insulin resistance in endocrine disease.

Authors:  Melpomeni Peppa; Chrysi Koliaki; Panagiotis Nikolopoulos; Sotirios A Raptis
Journal:  J Biomed Biotechnol       Date:  2010-03-15

Review 10.  The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action.

Authors:  E J Barrett; E M Eggleston; A C Inyard; H Wang; G Li; W Chai; Z Liu
Journal:  Diabetologia       Date:  2009-03-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.